APOE and Alzheimer disease: Early studies, based on a limited number of cases, found significantly decreased Aβ42 levels in CSF of CJD patients with mean values comparable to those of AD patients and with no apparent correlation with either the APOE genotype or the number of Aβ-positive plaques in the brain [34, 47, 71].